GLP-1 (also known as glucagon-like peptide-1) are a class of medications that were primarily used to treat type 2 diabetes, but have also been adopted to support individuals in weight loss
Physical activity plays an important role in maintaining weight loss after GLP-1 treatment
Blood samples were collected for metabolic profiling, followed by anthropometric measurement, body composition analysis, and MMTT
With 30 g of protein (more than any other food in the study), plus nine grams of fibre and plenty of healthy fats, this combination kept hunger at bay longer than any other food
These symptoms can be non-specific and may be mistakenly attributed to gastrointestinal side effects commonly associated with GLP-1 agonists, such as nausea or dyspepsia
These amyloid aggregates are toxic to -cells and are linked to the pancreatic pathophysiology of T2DM